Real-world Benefit of Apremilast Treatment of Patients With Moderate-to-severe Psoriasis After Transition From Fumaric Acid Esters
Latest Information Update: 30 Jan 2023
At a glance
- Drugs Apremilast (Primary) ; Fumarates
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Acronyms APART
- Sponsors Amgen; Celgene Corporation
- 23 Aug 2022 Status changed from active, no longer recruiting to completed.
- 27 May 2021 Status changed from recruiting to active, no longer recruiting.
- 28 Apr 2020 Planned End Date changed from 31 Dec 2020 to 27 May 2022.